These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP. Young MT; Pelegrin P; Surprenant A Mol Pharmacol; 2007 Jan; 71(1):92-100. PubMed ID: 17032903 [TBL] [Abstract][Full Text] [Related]
23. Pore formation is not associated with macroscopic redistribution of P2X7 receptors. Smart ML; Panchal RG; Bowser DN; Williams DA; Petrou S Am J Physiol Cell Physiol; 2002 Jul; 283(1):C77-84. PubMed ID: 12055075 [TBL] [Abstract][Full Text] [Related]
24. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor. Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492 [TBL] [Abstract][Full Text] [Related]
25. Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors. Schulze-Lohoff E; Hugo C; Rost S; Arnold S; Gruber A; Brüne B; Sterzel RB Am J Physiol; 1998 Dec; 275(6):F962-71. PubMed ID: 9843914 [TBL] [Abstract][Full Text] [Related]
26. Selective knock-down of P2X7 ATP receptor function by dominant-negative subunits. Raouf R; Chakfe Y; Blais D; Speelman A; Boué-Grabot E; Henderson D; Séguéla P Mol Pharmacol; 2004 Mar; 65(3):646-54. PubMed ID: 14978243 [TBL] [Abstract][Full Text] [Related]
27. Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice. Gartland A; Buckley KA; Hipskind RA; Perry MJ; Tobias JH; Buell G; Chessell I; Bowler WB; Gallagher JA Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):243-53. PubMed ID: 14696971 [TBL] [Abstract][Full Text] [Related]
28. P2X7 purinoceptor expression in Xenopus oocytes is not sufficient to produce a pore-forming P2Z-like phenotype. Petrou S; Ugur M; Drummond RM; Singer JJ; Walsh JV FEBS Lett; 1997 Jul; 411(2-3):339-45. PubMed ID: 9271232 [TBL] [Abstract][Full Text] [Related]
29. P2X7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. Suh BC; Kim JS; Namgung U; Ha H; Kim KT J Immunol; 2001 Jun; 166(11):6754-63. PubMed ID: 11359833 [TBL] [Abstract][Full Text] [Related]
30. Prion infection correlates with hypersensitivity of P2X7 nucleotide receptor in a mouse microglial cell line. Takenouchi T; Iwamaru Y; Imamura M; Kato N; Sugama S; Fujita M; Hashimoto M; Sato M; Okada H; Yokoyama T; Mohri S; Kitani H FEBS Lett; 2007 Jun; 581(16):3019-26. PubMed ID: 17544414 [TBL] [Abstract][Full Text] [Related]
31. Molecular and functional characterization of human P2X(2) receptors. Lynch KJ; Touma E; Niforatos W; Kage KL; Burgard EC; van Biesen T; Kowaluk EA; Jarvis MF Mol Pharmacol; 1999 Dec; 56(6):1171-81. PubMed ID: 10570044 [TBL] [Abstract][Full Text] [Related]
32. Activation of P2X(7) receptors decreases glutamate uptake and glutamine synthetase activity in RBA-2 astrocytes via distinct mechanisms. Lo JC; Huang WC; Chou YC; Tseng CH; Lee WL; Sun SH J Neurochem; 2008 Apr; 105(1):151-64. PubMed ID: 18067549 [TBL] [Abstract][Full Text] [Related]
33. Apparent species differences in the kinetic properties of P2X(7) receptors. Hibell AD; Kidd EJ; Chessell IP; Humphrey PP; Michel AD Br J Pharmacol; 2000 May; 130(1):167-73. PubMed ID: 10781013 [TBL] [Abstract][Full Text] [Related]
34. Astrocyte cultures exhibit P2X7 receptor channel opening in the absence of exogenous ligands. Nagasawa K; Escartin C; Swanson RA Glia; 2009 Apr; 57(6):622-33. PubMed ID: 18942742 [TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of U73122 and U73343 on Ca2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line. Takenouchi T; Ogihara K; Sato M; Kitani H Biochim Biophys Acta; 2005 Nov; 1726(2):177-86. PubMed ID: 16122875 [TBL] [Abstract][Full Text] [Related]
36. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Humphreys BD; Virginio C; Surprenant A; Rice J; Dubyak GR Mol Pharmacol; 1998 Jul; 54(1):22-32. PubMed ID: 9658186 [TBL] [Abstract][Full Text] [Related]
37. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Léon C; Vial C; Cazenave JP; Gachet C Gene; 1996 Jun; 171(2):295-7. PubMed ID: 8666290 [TBL] [Abstract][Full Text] [Related]
38. Tissue distribution of the P2X7 receptor. Collo G; Neidhart S; Kawashima E; Kosco-Vilbois M; North RA; Buell G Neuropharmacology; 1997 Sep; 36(9):1277-83. PubMed ID: 9364482 [TBL] [Abstract][Full Text] [Related]
39. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel. Wiley JS; Gargett CE; Zhang W; Snook MB; Jamieson GP Am J Physiol; 1998 Nov; 275(5):C1224-31. PubMed ID: 9814970 [TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. Takenouchi T; Sato M; Kitani H J Neurochem; 2007 Sep; 102(5):1518-1532. PubMed ID: 17437542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]